Literature DB >> 10930194

Long-term blood pressure telemetry in AT2 receptor-disrupted mice.

V Gross1, A F Milia, R Plehm, T Inagami, F C Luft.   

Abstract

OBJECTIVES: The hypertension in AT2 receptor knockout mice is imperfectly defined. Therefore, we investigated the influence of dietary salt loading and deoxycorticosterone (DOCA)-salt treatment on blood pressure and diurnal patterns of blood pressure in these mice by radiotelemetry.
METHODS: We used telemetry in AT2 receptor knockout and wild-type mice to measure blood pressure, heart rate, aortic pressure dp/dt, locomotor activity, and circadian rhythms. Salt-related effects were studied by increasing the salt in chow to 4%, adding 1% saline in drinking water, and by DOCA-salt treatment
RESULTS: Baseline blood pressures were higher in AT2 receptor knockout than in wild-type mice and were not affected by increasing the salt intake. The blood pressure increase was steeper and greater in AT2 receptor knockout than in wild-type mice after DOCA-salt treatment A circadian rhythm of blood pressure and heart rate, with higher values during the night, was seen in wild-type, but not in AT2 receptor knockout mice. In AT2 receptor knockout mice, this rhythm was only significant when daily salt intake was increased or when DOCA-salt hypertension was induced. The acrophase of blood pressure and heart rate was found between 2000 and 2400 h and was in accordance with the maximum physical activity.
CONCLUSION: These data suggest that AT2 knockout mice display slight hypertension which is not salt-sensitive. On the other hand, the susceptibility to develop DOCA-salt hypertension is increased. The study also illustrates the power of telemetry in monitoring long-term cardiovascular changes and circadian blood pressure and heart rate rhythms in genetically engineered mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930194     DOI: 10.1097/00004872-200018070-00018

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  19 in total

1.  Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension.

Authors:  Graziela Torres Blanch; André Henrique Freiria-Oliveira; Guilherme Fleury Fina Speretta; Eduardo J Carrera; Hongwei Li; Robert C Speth; Eduardo Colombari; Colin Sumners; Débora S A Colombari
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

Review 2.  Circadian clocks and vascular function.

Authors:  Georgios K Paschos; Garret A FitzGerald
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  Suppression of Resting Metabolism by the Angiotensin AT2 Receptor.

Authors:  Nicole K Littlejohn; Henry L Keen; Benjamin J Weidemann; Kristin E Claflin; Kevin V Tobin; Kathleen R Markan; Sungmi Park; Meghan C Naber; Francoise A Gourronc; Nicole A Pearson; Xuebo Liu; Donald A Morgan; Aloysius J Klingelhutz; Matthew J Potthoff; Kamal Rahmouni; Curt D Sigmund; Justin L Grobe
Journal:  Cell Rep       Date:  2016-07-28       Impact factor: 9.423

Review 4.  Protective Angiotensin Type 2 Receptors in the Brain and Hypertension.

Authors:  Annette D de Kloet; Ulrike M Steckelings; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

5.  The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats.

Authors:  Martina Winkler; Johanna Schuchard; Ines Stölting; Florian M Vogt; Jörg Barkhausen; Christoph Thorns; Michael Bader; Walter Raasch
Journal:  Br J Pharmacol       Date:  2016-03-27       Impact factor: 8.739

Review 6.  Angiotensin type 2 receptors: blood pressure regulation and end organ damage.

Authors:  Colin Sumners; Annette D de Kloet; Eric G Krause; Thomas Unger; Ulrike Muscha Steckelings
Journal:  Curr Opin Pharmacol       Date:  2015-02-09       Impact factor: 5.547

7.  Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.

Authors:  Ananthakrishnan Sankaranarayanan; Girija Raman; Christoph Busch; Tim Schultz; Pavel I Zimin; Joachim Hoyer; Ralf Köhler; Heike Wulff
Journal:  Mol Pharmacol       Date:  2008-10-27       Impact factor: 4.436

8.  New function for an old enzyme: NEP deficient mice develop late-onset obesity.

Authors:  Matthias Becker; Wolf-Eberhard Siems; Reinhart Kluge; Florian Gembardt; Heinz-Peter Schultheiss; Michael Schirner; Thomas Walther
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

Review 9.  Pressed for time: the circadian clock and hypertension.

Authors:  R Daniel Rudic; David J Fulton
Journal:  J Appl Physiol (1985)       Date:  2009-08-13

Review 10.  Dimerization of AT2 and Mas Receptors in Control of Blood Pressure.

Authors:  Sanket Patel; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.